| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 0.14× | 0.14× | 0.04× | 0.05× | 0.06× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| — | — | 0.27× | — | — | ||
| 0.18× | 0.18× | 0.19× | 0.21× | 0.21× | ||
| −2.35× | −2.35× | 1.44× | −1.68× | 0.56× | ||
| −1.03× | −1.03× | 0.77× | −0.83× | 0.29× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 0.06 | 0.05 | 0.04 | 0.14 | 0.14 | |
| Working Capital Turnover | — | — | 0.27 | — | — | |
| Asset Turnover | 0.21 | 0.21 | 0.19 | 0.18 | 0.18 | |
| Cash Conversion (CFO/Net Income) | 0.56 | -1.68 | 1.44 | -2.35 | -2.35 | |
| CFO/EBITDA | 0.29 | -0.83 | 0.77 | -1.03 | -1.03 |